Loading the company…
Loading the company…
Families: Coronary intervention (PCI), Peripheral arterial intervention.
All companies · Product and company coverage
In the last ten years FDA made 5 decisions for Orbusneich Medical Trading (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2018 (3). The latest was on 2020-03-04.
| Family | Decisions on record |
|---|---|
| Coronary intervention (PCI) | 4 |
| Peripheral arterial intervention | 1 |
| Jade PTA Balloon Dilatation Catheter |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Orbusneich Medical Trading.